Biotricity, Inc. (BTCY) Financials

BTCY Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 5.5 million 32.2 million
2023-09-30 6.8 million 32.3 million
2023-06-30 6.1 million 29.6 million
2023-03-31 6.5 million 26.4 million

BTCY Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -1.3 million 170140
2023-09-30 -2.4 million 163335
2023-06-30 -1.8 million 211180
2023-03-31 -1.9 million 281978

BTCY Net Income

No data available :(

BTCY Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - 1.5 million
2023-09-30 1.2 million - 1.5 million
2023-06-30 51433 - 1.6 million
2023-03-31 570460 - 1.7 million

BTCY Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 9.4 million
2023-09-30 8.8 million
2023-06-30 8.8 million
2023-03-31 8.7 million

BTCY Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 452956 3.0 million -
2023-09-30 - 697620 3.5 million -
2023-06-30 - 712975 3.5 million -
2023-03-31 - 703329 3.1 million -

BTCY Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 3.0 million 804986
2023-09-30 2.9 million 892019
2023-06-30 3.0 million 1.1 million
2023-03-31 2.7 million 1.2 million

BTCY

Price: $1.30

52 week price:
0.45
3.78

Earnings Per Share: -1.75 USD

P/E Ratio: -0.41

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Volume: 195900

Market Capitalization: 10.6 million

Links: